FDG-PET-CT scans as a decision tool for early immunotherapy discontinuation in advanced melanoma

In this MEDtalk Eva Ellebæk, MD at the National Center for Cancer Immune Therapy, Copenhagen University Hospital, gives an answer to the question if we can use routine FDG-PET-CT scans as a decision tool for early immunotherapy discontinuation in advanced melanoma.